73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Phase 3 clinical trial: Brain cancer vaccine shows promising results

Phase 3 clinical trial: Brain cancer vaccine shows promising results

byKing's College LondonOverall Survival for Patients With Recurrent Glioblastoma Kaplan-Meier plot comparing overall survival for patients with recurrent glioblastoma treated with autologous

Phase 3 clinical trial: Brain cancer vaccine shows promising results

byKing's College LondonOverall Survival for Patients With Recurrent Glioblastoma Kaplan-Meier plot comparing overall survival for patients with recurrent glioblastoma treated with autologous
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
What Thick Blood Means and How It’s Treated

What Thick Blood Means and How It’s Treated

What Thick Blood Means and How It’s TreatedAlso Called HypercoagulabilityByKathi ValeiiUpdated on November 12, 2023Medically reviewed byRichard N. Fogoros, MDHaving thick blood

What Thick Blood Means and How It’s Treated

What Thick Blood Means and How It’s TreatedAlso Called HypercoagulabilityByKathi ValeiiUpdated on November 12, 2023Medically reviewed byRichard N. Fogoros, MDHaving thick blood
Neurosurgery: new augmented reality technology helps to complete multiple surgeries

Neurosurgery: new augmented reality technology helps to complete multiple surgeries

Augmented reality accurate localization, assisting endoscopic cerebral hematoma removal surgeryThe Department of Neurosurgery (Digital/Secure Neurosurgery) of the East Campus accurately localized a

Neurosurgery: new augmented reality technology helps to complete multiple surgeries

Augmented reality accurate localization, assisting endoscopic cerebral hematoma removal surgeryThe Department of Neurosurgery (Digital/Secure Neurosurgery) of the East Campus accurately localized a
Universal Blood Type Donors and Recipients

Universal Blood Type Donors and Recipients

Universal Blood Type Donors and RecipientsWho can donate blood to anyone or receive blood of any typeByCherie Berkley, MSUpdated on August 05, 2023Medically reviewed byDavid Ha

Universal Blood Type Donors and Recipients

Universal Blood Type Donors and RecipientsWho can donate blood to anyone or receive blood of any typeByCherie Berkley, MSUpdated on August 05, 2023Medically reviewed byDavid Ha
Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

October 6, 2023Ashling WahnerThe Medicines and Healthcare Products Regulatory Agency has authorized the use of dostarlimab in combination with chemotherapy for the treatment of patients with mismatch

Dostarlimab Plus Chemo Wins MHRA Approval for dMMR/MSI-H Primary Advanced/Recurrent

October 6, 2023Ashling WahnerThe Medicines and Healthcare Products Regulatory Agency has authorized the use of dostarlimab in combination with chemotherapy for the treatment of patients with mismatch
European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

October 6, 2023Kristi RosaA Type II extension of indication application seeking the approval of amivantamab in combination with carboplatin and pemetrexed for the frontline treatment of adult patients

European Approval Sought for Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC

October 6, 2023Kristi RosaA Type II extension of indication application seeking the approval of amivantamab in combination with carboplatin and pemetrexed for the frontline treatment of adult patients
How Successful Is Immunotherapy for Breast Cancer?

How Successful Is Immunotherapy for Breast Cancer?

ByMaxine LipnerPublished on August 18, 2023Medically reviewed byDoru Paul, MDImmunotherapycan boost your body's immune response to cancer cells and hopefully kill the

How Successful Is Immunotherapy for Breast Cancer?

ByMaxine LipnerPublished on August 18, 2023Medically reviewed byDoru Paul, MDImmunotherapycan boost your body's immune response to cancer cells and hopefully kill the
New potential therapeutic approach for HER2-positive breast cancer discovered

New potential therapeutic approach for HER2-positive breast cancer discovered

by Leibniz Research Centre for Working Environments and Human Factors in DortmundEDI3 expression and enzyme activity according to HER2 and ER status. A, EDI3 (GPCPD1; 224826_at) mRNA expression was co

New potential therapeutic approach for HER2-positive breast cancer discovered

by Leibniz Research Centre for Working Environments and Human Factors in DortmundEDI3 expression and enzyme activity according to HER2 and ER status. A, EDI3 (GPCPD1; 224826_at) mRNA expression was co
Gene linked to glioblastoma stem cell self-renewal and immunosuppression

Gene linked to glioblastoma stem cell self-renewal and immunosuppression

by Olivia Dimmer,Northwestern UniversityWorking model. a, Illustration shows a proposed mechanism for the TFPI2 and its associated signaling axis in regulating self-renewal of glioma stem cells

Gene linked to glioblastoma stem cell self-renewal and immunosuppression

by Olivia Dimmer,Northwestern UniversityWorking model. a, Illustration shows a proposed mechanism for the TFPI2 and its associated signaling axis in regulating self-renewal of glioma stem cells
Cancer Cells vs. Normal Cells: How Are They Different?

Cancer Cells vs. Normal Cells: How Are They Different?

Cancer Cells vs. Normal Cells: How Are They Different?ByLynne Eldridge, MDUpdated on April 21, 2023Medically reviewed byDoru Paul, MDCancercells are different from normal

Cancer Cells vs. Normal Cells: How Are They Different?

Cancer Cells vs. Normal Cells: How Are They Different?ByLynne Eldridge, MDUpdated on April 21, 2023Medically reviewed byDoru Paul, MDCancercells are different from normal